The role of oxidative stress in the toxicity of pyridoxal isonicotinoyl hydrazone (PIH) analogues

被引:20
作者
Buss, JL [1 ]
Neuzil, J [1 ]
Ponka, P [1 ]
机构
[1] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
关键词
glutathione; iron chelators; lipid peroxidation;
D O I
10.1042/bst0300755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Pyridoxal isonicotinoyl hydrazone (PIH) analogues are effective iron chelators in vivo and in-vitro, and may be of value for the treatment of secondary iron overload. The sensitivity of Jurkat cells to Fe-chelator complexes was enhanced several-fold by the depletion of the antioxidant glutathione, indicating the role of oxidative stress in their toxicity. K562 cells loaded with eicosapentaenoic acid, a fatty acid particularly susceptible to oxidation, were also more sensitive to the toxic effects of the Fe complexes, and toxicity was proportional to lipid peroxidation. Thus Fe-chelator complexes cause oxidative stress, which may be a major component of their toxicity. As was the case for their Fe complexes, the toxicity of PIH analogues was enhanced by glutathione depletion of Jurkat cells and eicosapentaenoic acid-loading of K562 cells. Thus the toxicity of the chelators themselves is also enhanced by compromised cellular redox status. In addition, the toxicity of the chelators was diminished by culturing Jurkat cells under hypoxic conditions, which may limit the production of the reactive oxygen species that initiate oxidative stress. A significant part of the toxicity of the chelators may be due to intracellular formation of Fe-chelator complexes, which oxidatively destroy the cell.
引用
收藏
页码:755 / 757
页数:3
相关论文
共 12 条
[1]
EVALUATION OF THE IRON CHELATION POTENTIAL OF HYDRAZONES OF PYRIDOXAL, SALICYLALDEHYDE AND 2-HYDROXY-1-NAPHTHYLALDEHYDE USING THE HEPATOCYTE IN CULTURE [J].
BAKER, E ;
RICHARDSON, D ;
GROSS, S ;
PONKA, P .
HEPATOLOGY, 1992, 15 (03) :492-501
[2]
Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone [J].
Bláha, K ;
Cikrt, M ;
Nerudová, J ;
Fornusková, H ;
Ponka, P .
BLOOD, 1998, 91 (11) :4368-4372
[3]
BUETTNER GR, 1990, METHOD ENZYMOL, V186, P125
[4]
BILIARY IRON EXCRETION IN RATS FOLLOWING PYRIDOXAL ISONICOTINOYL HYDRAZONE [J].
CIKRT, M ;
PONKA, P ;
NECAS, E ;
NEUWIRT, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 45 (02) :275-283
[5]
EDWARD JT, 1995, BIOMETALS, V8, P209
[6]
Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals.: Analytical applications to a colorimetric assay of lipid peroxidation [J].
Gérard-Monnier, D ;
Erdelmeier, I ;
Régnard, K ;
Moze-Henry, N ;
Yadan, JC ;
Chaudière, J .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (10) :1176-1183
[7]
A STUDY OF THE MECHANISM OF ACTION OF PYRIDOXAL ISONICOTINOYL HYDRAZONE AT THE CELLULAR-LEVEL USING RETICULOCYTES LOADED WITH NON-HEME FE-59 [J].
HUANG, AR ;
PONKA, P .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 757 (03) :306-315
[8]
Iron-chelating therapy and the treatment of thalassemia [J].
Olivieri, NF ;
Brittenham, GM .
BLOOD, 1997, 89 (03) :739-761
[9]
EFFECT OF PYRIDOXAL ISONICOTINOYL HYDRAZONE AND OTHER HYDRAZONES ON IRON RELEASE FROM MACROPHAGES, RETICULOCYTES AND HEPATOCYTES [J].
PONKA, P ;
RICHARDSON, D ;
BAKER, E ;
SCHULMAN, HM ;
EDWARD, JT .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 967 (01) :122-129
[10]
Qian J, 2001, ACTA PHARMACOL SIN, V22, P821